Bleichroeder LP Dia Medica Therapeutics Inc. Transaction History
Bleichroeder LP
- $323 Million
- Q1 2024
A detailed history of Bleichroeder LP transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Bleichroeder LP holds 222,317 shares of DMAC stock, worth $622,487. This represents 0.19% of its overall portfolio holdings.
Number of Shares
222,317
Previous 222,317
-0.0%
Holding current value
$622,487
Previous $631,000
2.54%
% of portfolio
0.19%
Previous 0.18%
Shares
2 transactions
Others Institutions Holding DMAC
# of Institutions
33Shares Held
3.85MCall Options Held
5.9KPut Options Held
1.4K-
Vanguard Group Inc Valley Forge, PA1.01MShares$2.84 Million0.0% of portfolio
-
First Manhattan CO New York, NY850KShares$2.38 Million0.01% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX500KShares$1.4 Million2.47% of portfolio
-
Geode Capital Management, LLC Boston, MA239KShares$669,8580.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA209KShares$586,1290.0% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $74M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...